Analytical Data
-
Gene name
hfb1
- Application
-
Alternative Names
Hydrophobin I Short name:HFBI
-
Species
Hypocrea jecorina
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P52754
-
Expression Region
23-97aa
-
Molecular Weight
23.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HFB1, or Hypoxia-Inducible Factor-1, is a critical regulator of cellular responses to hypoxia (low oxygen levels) and plays a vital role in various physiological and pathological processes, including tumor growth, angiogenesis, and inflammation. The study of recombinant HFB1 protein has gained significant attention in the field of biomedical research due to its potential applications in cancer therapy and regenerative medicine. By understanding the molecular mechanisms underlying HFB1's role in gene expression regulation under hypoxic conditions, researchers aim to uncover novel therapeutic strategies that can enhance oxygen delivery to tissues or inhibit tumor progression. The production of recombinant HFB1 protein allows for detailed biochemical analyses and functional assays, enabling investigators to dissect its interactions with other cellular signaling pathways. Moreover, the recombinant protein can be utilized in drug screening and development, as well as in the design of HFB1-based therapies that could improve outcomes for patients with hypoxia-related diseases. As such, the ongoing research efforts surrounding HFB1 and its recombinant form hold the promise of advancing our understanding of cellular oxygen sensing and developing innovative clinical applications.
